Security key
69353Y103
PMV Pharmaceuticals, Inc. - Common Stock, $0.00001 par value per share (PMVP)
CUSIP: 69353Y103
Q1 2025 13F Holders as of 31 Mar 2025
- Type / Class
- Equity / Common Stock, $0.00001 par value per share
- Shares outstanding
- 53,625,367
- Total 13F shares
- 37,320,031
- Share change
- -1,639,060
- Total reported value
- $40,676,123
- Put/Call ratio
- 5.9%
- Price per share
- $1.09
- Number of holders
- 54
- Value change
- -$2,281,115
- Number of buys
- 10
- Number of sells
- 47
Report period
Q1 2025
Institutions
54
Top holders
10
PMVP full security history
Newer quarter: Q2 2025
Previous quarter: Q4 2024
PMV Pharmaceuticals, Inc. SEC filings
PMV Pharmaceuticals, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 69353Y103
Recent filing periods:
Top shareholders of PMVP - PMV Pharmaceuticals, Inc. - Common Stock, $0.00001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC |
13F
|
Company |
12%
|
6,475,291
|
$9,777,689 | — | 31 Dec 2024 | |
| Sio Capital Management, LLC |
13F
|
Company |
6.7%
|
3,572,167
|
$5,393,972 | — | 31 Dec 2024 | |
| ArrowMark Colorado Holdings LLC |
13F
|
Company |
6.5%
|
3,508,451
|
$5,297,761 | — | 31 Dec 2024 | |
| BML Capital Management, LLC |
13F
|
Company |
6.5%
|
3,466,684
|
$5,234,693 | — | 31 Dec 2024 | |
| Euclidean Capital LLC |
13F
3/4/5
|
Company · 10%+ Owner |
4.9%
|
2,627,643
|
$3,967,741 | — | 31 Dec 2024 | |
| ALKEON CAPITAL MANAGEMENT LLC |
13F
|
Company |
4.4%
|
2,343,731
|
$3,539,033 | — | 31 Dec 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
4%
|
2,143,102
|
$3,236,084 | — | 31 Dec 2024 | |
| PFM Health Sciences, LP |
13F
|
Company |
3.9%
|
2,079,245
|
$3,139,660 | — | 31 Dec 2024 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
3.9%
|
2,078,866
|
$3,136,000 | — | 31 Dec 2024 | |
| BlackRock, Inc. |
13F
|
Company |
2.1%
|
1,146,484
|
$1,731,190 | — | 31 Dec 2024 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
1.9%
|
1,024,288
|
$1,546,675 | — | 31 Dec 2024 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
1.3%
|
714,600
|
$1,079,046 | — | 31 Dec 2024 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
1%
|
539,893
|
$815,238 | — | 31 Dec 2024 | |
| Stonepine Capital Management, LLC |
13F
|
Company |
1%
|
535,805
|
$809,066 | — | 31 Dec 2024 | |
| CITIGROUP INC |
13F
|
Company |
0.96%
|
514,911
|
$777,516 | — | 31 Dec 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.95%
|
506,986
|
$765,549 | — | 31 Dec 2024 | |
| Aldebaran Capital, LLC |
13F
|
Company |
0.94%
|
502,190
|
$758,307 | — | 31 Dec 2024 | |
| Peapod Lane Capital LLC |
13F
|
Company |
0.83%
|
445,744
|
$673,073 | — | 31 Dec 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.79%
|
421,710
|
$636,963 | — | 31 Dec 2024 | |
| M&T BANK CORP |
13F
|
Company |
0.75%
|
399,548
|
$603,659 | — | 31 Dec 2024 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
0.69%
|
370,920
|
$560,089 | — | 31 Dec 2024 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
0.6%
|
322,024
|
$486,256 | — | 31 Dec 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.59%
|
318,020
|
$480,210 | — | 31 Dec 2024 | |
| UBS Group AG |
13F
|
Company |
0.51%
|
275,464
|
$415,951 | — | 31 Dec 2024 | |
| RBF Capital, LLC |
13F
|
Company |
0.46%
|
245,561
|
$379,967 | — | 31 Dec 2024 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.38%
|
202,100
|
$305,171 | — | 31 Dec 2024 | |
| STATE STREET CORP |
13F
|
Company |
0.29%
|
157,578
|
$237,943 | — | 31 Dec 2024 | |
| Shay Capital LLC |
13F
|
Company |
0.29%
|
156,451
|
$236,241 | — | 31 Dec 2024 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
0.29%
|
153,701
|
$232,089 | — | 31 Dec 2024 | |
| EVOKE WEALTH, LLC |
13F
|
Company |
0.25%
|
133,122
|
$201,014 | — | 31 Dec 2024 | |
| Walleye Capital LLC |
13F
|
Company |
0.24%
|
127,626
|
$192,715 | — | 31 Dec 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.23%
|
126,004
|
$190,238 | — | 31 Dec 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.23%
|
121,245
|
$183,080 | — | 31 Dec 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.2%
|
107,888
|
$162,911 | — | 31 Dec 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.2%
|
107,340
|
$162,083 | — | 31 Dec 2024 | |
| ADAR1 Capital Management, LLC |
13F
|
Company |
0.19%
|
101,008
|
$152,522 | — | 31 Dec 2024 | |
| PANAGORA ASSET MANAGEMENT INC |
13F
|
Company |
0.17%
|
89,631
|
$135,343 | — | 31 Dec 2024 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.14%
|
73,015
|
$110,253 | — | 31 Dec 2024 | |
| PNC FINANCIAL SERVICES GROUP, INC. |
13F
|
Company |
0.13%
|
69,113
|
$104,361 | — | 31 Dec 2024 | |
| Marquette Asset Management, LLC |
13F
|
Company |
0.12%
|
64,009
|
$96,654 | — | 31 Dec 2024 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.09%
|
49,870
|
$75,304 | — | 31 Dec 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.08%
|
44,568
|
$67,297 | — | 31 Dec 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.08%
|
41,763
|
$63,062 | — | 31 Dec 2024 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.08%
|
40,384
|
$61,000 | — | 31 Dec 2024 | |
| HSBC HOLDINGS PLC |
13F
|
Company |
0.07%
|
39,080
|
$58,034 | — | 31 Dec 2024 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.07%
|
35,200
|
$53,152 | — | 31 Dec 2024 | |
| Velan Capital Investment Management LP |
13F
|
Company |
0.07%
|
35,000
|
$52,850 | — | 31 Dec 2024 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.06%
|
33,600
|
$51,000 | — | 31 Dec 2024 | |
| Point72 Asia (Singapore) Pte. Ltd. |
13F
|
Company |
0.06%
|
32,603
|
$49,231 | — | 31 Dec 2024 | |
| BARCLAYS PLC |
13F
|
Company |
0.06%
|
30,197
|
$45,597 | — | 31 Dec 2024 |
Institutional Holders of PMV Pharmaceuticals, Inc. - Common Stock, $0.00001 par value per share (PMVP) as of Q1 2025
As of 31 Mar 2025,
PMV Pharmaceuticals, Inc. - Common Stock, $0.00001 par value per share (PMVP) was held by
54 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
37,320,031 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, BML Capital Management, LLC, Sio Capital Management, LLC, ArrowMark Colorado Holdings LLC, PFM Health Sciences, LP, Euclidean Capital LLC, ALKEON CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC, ACADIAN ASSET MANAGEMENT LLC, and BlackRock, Inc..
This page lists
54
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2025 vs Q4 2024 Across Filers
Q4 2024 holders
70
Q1 2025 holders
54
Holder diff
-16
| Investor | Q4 2024 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q4 2024 Value $ | Q1 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.